Citadel Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275K Buy
94,300
+32,600
+53% +$93.2K ﹤0.01% 10665
2025
Q4
$152K Sell
61,700
-57,900
-48% -$138K ﹤0.01% 11301
2025
Q3
$267K Sell
119,600
-60,700
-34% -$139K ﹤0.01% 10624
2025
Q2
$435K Buy
180,300
+20,000
+12% +$48.7K ﹤0.01% 8959
2025
Q1
$373K Buy
160,300
+136,200
+565% +$272K ﹤0.01% 9103
2024
Q4
$44.6K Sell
24,100
-12,000
-33% -$26.5K ﹤0.01% 12505
2024
Q3
$88.1K Buy
36,100
+25,900
+254% +$58.1K ﹤0.01% 11288
2024
Q2
$20.9K Sell
10,200
-7,600
-43% -$17.3K ﹤0.01% 12596
2024
Q1
$44.1K Sell
17,800
-132,300
-88% -$345K ﹤0.01% 12294
2023
Q4
$420K Sell
150,100
-28,400
-16% -$76.7K ﹤0.01% 8469
2023
Q3
$461K Sell
178,500
-2,600
-1% -$7.52K ﹤0.01% 8235
2023
Q2
$576K Sell
181,100
-48,100
-21% -$142K ﹤0.01% 7630
2023
Q1
$646K Buy
229,200
+90,200
+65% +$236K ﹤0.01% 7765
2022
Q4
$378K Sell
139,000
-14,700
-10% -$42.8K ﹤0.01% 8834
2022
Q3
$435K Buy
153,700
+18,900
+14% +$53.6K ﹤0.01% 8773
2022
Q2
$338K Sell
134,800
-30,900
-19% -$88.1K ﹤0.01% 9544
2022
Q1
$535K Sell
165,700
-165,600
-50% -$463K ﹤0.01% 9223
2021
Q4
$928K Sell
331,300
-223,200
-40% -$640K ﹤0.01% 8137
2021
Q3
$1.53M Buy
554,500
+324,700
+141% +$1.03M ﹤0.01% 7038
2021
Q2
$791K Buy
229,800
+124,200
+118% +$404K ﹤0.01% 8971
2021
Q1
$289K Buy
105,600
+64,100
+154% +$181K ﹤0.01% 10940
2020
Q4
$127K Buy
41,500
+24,900
+150% +$67.2K ﹤0.01% 10054
2020
Q3
$38K Buy
+16,600
New +$41.6K ﹤0.01% 9684
2020
Q2
Sell
-10,300
Closed -$24K 9688
2020
Q1
$24K Hold
10,300
﹤0.01% 9254
2019
Q4
$48K Buy
+10,300
New +$45.7K ﹤0.01% 8762
2019
Q2
Sell
-11,700
Closed -$50K 9086
2019
Q1
$50K Buy
+11,700
New +$53.7K ﹤0.01% 8814
2017
Q2
Sell
-13,800
Closed -$79K 7399
2017
Q1
$79K Buy
+13,800
New +$75.7K ﹤0.01% 6932

Other funds holding ABEV

Citadel Advisors's ABEV Position: Q1 2026 in Review

Citadel Advisors increased its Ambev (ABEV) stake by 80% in Q1 2026, buying an estimated $8.28M and bringing the position to 6,526,986 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Citadel Advisors first reported a position in ABEV in Q1 2014 and has held it in 44 quarters since. The position peaked at $46.9M in Q2 2020. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Citadel Advisors held 6,526,986 shares of Ambev worth $19.1M as of Q1 2026.
  • Citadel Advisors bought 2,898,174 Ambev shares in Q1 2026, an estimated $8.28M.
  • Ambev made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2392 holding.
  • Citadel Advisors first reported a position in Ambev in Q1 2014 and has held it in 44 quarters since.
  • Citadel Advisors's Ambev position peaked at $46.9M in Q2 2020.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.